Article
Molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia: implications for genetic counseling.
American journal of pharmacogenomics : genomics-related research in drug development and clinical practice - 1 Jan 2001
Speiser P W
Abstract excerpt
Congenital adrenal hyperplasia (CAH) is an inherited disorder of steroid biosynthesis most often attributable to mutations in CYP21 (also termed CYP21A2) encoding the active steroid 21-hydroxylase enzyme. This review focuses on clinical and genetic aspects of CAH, and updates the reader on current methodology and applications for molecular genetic diagnosis. Genotyping patients with CAH has revealed > 50...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
